DKK1 Promotes Epithelial–Mesenchymal Transition and Cisplatin Resistance in Gastric Cancer via Activation of the PI3K/AKT Pathway

Jian Li(Guizhou University), Li Feng(Fudan University)

Cancers

September 27, 2023

10.3390/cancers15194756

Cited by 13

Related Papers

Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

|Nature Communications|2020|121

Right hemicolectomy and multivisceral resection of right colon cancer: A report of 21 cases

|Journal of Huazhong University of Science and Technology [Medical Sciences]|2015|12

Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China

|Frontiers in Oncology|2021|12

FLAG-IDA as frontline induction improves outcomes in pediatric patients with core-binding factor or KMT2A-rearranged acute myeloid leukemia: A multicenter cohort study in southern China

|Blood|2025|1

[Treatment of advanced Siewert type Ⅱ esophagogastric junction adenocarcinoma by thoracoabdominal radical gastrectomy and D2 lymphadenectomy].

|PubMed|2016|0